Echo Street Capital Management LLC Iovance Biotherapeutics, Inc. Transaction History

Echo Street Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$12.38 - $19.1 $155,529 - $239,953	-12,563 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $238,121 - $397,540	-14,388 Reduced 53.39%	12,563 $240,000
Q3 2021 Nov 15, 2021	BUY	$20.35 - $26.63 $548,452 - $717,705	26,951 New	26,951 $665,000
Q2 2021 Aug 16, 2021	SELL	$16.33 - $33.07 $169,031 - $342,307	-10,351 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$28.67 - $52.59 $296,763 - $544,359	10,351 New	10,351 $328,000

342

247M

2.51M

3.5M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $573M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.